Home › Qatar › Spravato

Spravato Nasal spray

Esketamine HCl 37.1 mg / Device equivalent to 32.2 mg esketamine base, includes an overfill to ensure a nominal delivered dose of 28 · Qatar

Listed price in Qatar

1114 QAR

Generic name: Esketamine HCl 37.1 mg / Device equivalent to 32.2 mg esketamine base, includes an overfill to ensure a nominal delivered dose of 28
Dosage form: Nasal spray
Pack: 1 Device

About esketamine hcl + device equivalent to esketamine base + includes an overfill to ensure a nominal delivered dose of

NMDA receptor antagonist antidepressant

Used for

Treatment-resistant depression in adults, alongside an oral antidepressant.
Depressive symptoms in adults with major depression and acute suicidal thoughts or behavior, alongside an oral antidepressant.

Usual adult dose

Clinician-administered nasal doses vary by indication and treatment stage; typically twice weekly initially, then reduced to weekly or every one to two weeks.

Common side effects

Dissociation, dizziness, sleepiness, and impaired coordination
Nausea, vomiting, and altered taste
Increased blood pressure
Feeling detached or intoxicated

Important warnings

Can cause sedation, dissociation, and impaired alertness; monitoring is required after each dose.
Blood pressure can rise; assess before and after treatment.
Risk of misuse and dependence; restricted distribution and supervised administration apply.
Avoid driving or hazardous activities until the next day after restful sleep.

Pregnancy

May cause fetal harm based on animal findings; pregnancy data are limited. Use during pregnancy is generally avoided.

Breastfeeding

Breastfeeding is not recommended during treatment and for a period after the final dose; discuss timing with a clinician.

Interactions

Central nervous system depressants, including opioids and benzodiazepines, can increase sedation.
Psychostimulants and monoamine oxidase inhibitors may increase blood pressure.

AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.

Alternatives with Esketamine HCl 37.1 mg / Device equivalent to 32.2 mg esketamine base, includes an overfill to ensure a nominal delivered dose of 28 in Qatar

Same active ingredient: same strength and form first, then by listed price. Pack sizes may differ; ask your pharmacist before switching.

Spravato
Esketamine HCl 37.1 mg / Device equivalent to 32.2 mg esketamine base, includes an overfill to ensure a nominal delivered dose of 28 · Nasal spray · 2 Devices

2227 QAR
Spravato
Esketamine HCl 37.1 mg / Device equivalent to 32.2 mg esketamine base, includes an overfill to ensure a nominal delivered dose of 28 · Nasal spray · 3 Devices

3341 QAR